Investors

Sharing Discoveries

Saverna Therapeutics to date has been financed through a mixture of self-funding, grant awards from Switzerland and Europe via Innosuisse and Eurostars programs.

Become a part

Contact Us

Would you like to find out more about investment opportunities with Saverna Therapeutics or would you like to be a part of our journey on creating new innovative solutions for the world?

Get in touch with us.

For humanity, together

Why invest in Saverna

Participate in the fast-growing drug discovery and drug development space against the background of needs in the global health care system.
Opportunity for comparatively rapid project related returns on investment due to Saverna's business model (B2B early licensing or partnering).
The Directors & Executive Management have a unique blend of complementary skills, experiences and track records which allowed to develop the proprietary Saverna platform and its applications to the present level.
The company's business strategy and business model is in line with the industry's needs to address a number of paradigm changing pressure points e.g. adapt business model to reinforce innovation via external R&D collaborations due to thinning drug pipelines, focusing on health outcomes also in neglected disease areas, reducing costs to accommodate pricing and regulatory pressure, etc.(moving from Pharma 1.0 to Pharma 3.0).
The Company has close ties within leading academia, pharma/biotech companies and has developed excellent working relationships with other key players in the healthcare and pharma/biotech eco-system in Europe, US and Asia-Pacific.